BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25296734)

  • 1. Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway.
    Obchoei S; Sawanyawisuth K; Wongkham C; Kasinrerk W; Yao Q; Chen C; Wongkham S
    Tumour Biol; 2015 Feb; 36(2):849-59. PubMed ID: 25296734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
    Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
    Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
    Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
    Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophilin A Enhances Cell Proliferation and Xenografted Tumor Growth of Early Gastric Cancer.
    Feng W; Xin Y; Xiao Y; Li W; Sun D
    Dig Dis Sci; 2015 Sep; 60(9):2700-11. PubMed ID: 26008617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
    Jinawath A; Akiyama Y; Sripa B; Yuasa Y
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophilin A/CD147 signaling induces the epithelial-to-mesenchymal transition and renal fibrosis in chronic allograft dysfunction by regulating p38 MAPK signaling.
    Liu X; Tang Z; Jiang X; Wang T; Zhao L; Xu Z; Liu K
    Ren Fail; 2022 Dec; 44(1):1585-1594. PubMed ID: 36203223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of CyclophilinA/CD147 Axis Induces Cell Apoptosis and Inhibits Glioma Aggressiveness.
    Xu S; Hu C; Xiao Z; Luo C; Liu Z
    Biomed Res Int; 2020; 2020():7035847. PubMed ID: 32775435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
    Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ
    J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma.
    Sakamoto M; Miyagaki T; Kamijo H; Oka T; Boki H; Takahashi-Shishido N; Suga H; Sugaya M; Sato S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD147 stimulates hepatoma cells escaping from immune surveillance of T cells by interaction with Cyclophilin A.
    Ren YX; Wang SJ; Fan JH; Sun SJ; Li X; Padhiar AA; Zhang JN
    Biomed Pharmacother; 2016 May; 80():289-297. PubMed ID: 27133068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophilin A is a factor of antitumor defense in the early stages of tumor development.
    Kalinina A; Golubeva I; Kudryavtsev I; Khromova N; Antoshina E; Trukhanova L; Gorkova T; Kazansky D; Khromykh L
    Int Immunopharmacol; 2021 May; 94():107470. PubMed ID: 33640856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells.
    Gentilini A; Lori G; Caligiuri A; Raggi C; Di Maira G; Pastore M; Piombanti B; Lottini T; Arcangeli A; Madiai S; Navari N; Banales JM; Di Matteo S; Alvaro D; Duwe L; Andersen JB; Tubita A; Tusa I; Di Tommaso L; Campani C; Rovida E; Marra F
    Hepatology; 2021 Oct; 74(4):2007-2020. PubMed ID: 33959996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway.
    Dana P; Kariya R; Lert-Itthiporn W; Seubwai W; Saisomboon S; Wongkham C; Okada S; Wongkham S; Vaeteewoottacharn K
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
    Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
    Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
    Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of FOXO4 Inhibits Cholangiocarcinoma Cell Proliferation
    Intuyod K; Chomwong S; Thongpon P; Vaeteewoottacharn K; Pairojkul C; Pinlaor P; Pinlaor S
    Anticancer Res; 2020 Dec; 40(12):6899-6905. PubMed ID: 33288583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma.
    Yue C; Yang M; Tian Q; Mo F; Peng J; Ma Y; Huang Y; Wang D; Wang Y; Hu Z
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):817-825. PubMed ID: 29991293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.